Moreover, EVs from head and neck squamous cell carcinoma also exerted an effect, both in vitro and in vivo, in driving tumor angiogenesis through the ephrin type B receptor 2 (EPHB2) [70]. This evidence concerns the gene EPHB2 and neoplasm.